Back to results
US 11,884,708 B2Granted
Stapled peptide inhibitors of nemo as potential anti-inflammatory and anti-cancer drugs
AssigneeInstitut Pasteur
InventorsFabrice Agou, Alix Boucharlat, Yves-Marie Coic, Françoise Baleux
Life of this patent
Estimating the term…
Abstract
The invention concerns stapled peptide inhibitors of NEMO which inhibit the Nuclear Factor κB (NF-κB) signaling pathway and are useful as medicine candidates, in particular as anti-inflammatory or anticancer drugs.
Claims15
A peptide, comprising an amino sequence (I) which is at least 60% identical to the amino acid sequence SEQ ID NO:
- 1, and further comprising at least one macrocycle-forming linker connecting a first amino acid to a second amino acid of said sequence (I),
- wherein the sequence (I) consists of:
- (SEQ ID NO:
- 2)
- LKX1QAX2X3YK X4RFX5X6X7R X8ARX9K,
- in which:
- X1 is A;
- X2 is a cross-linked amino acid;
- X3 is I;
- X4 is A;
- X5 is a cross-linked amino acid;
- X6 is A;
- X7 is E;
- X8 is H or Q;
- and
- X9 is E;
- providing that X2 and X5 are cross-linked by the macrocycle-forming linker.
14 more elements
Dependencies are inferred from the claim text.